Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

240 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observe the clinical efficacy and safety of Recombinant Human Growth Hormone Injection assisted in the treatment of the patients with poor ovarian response in vitro fertilization and embryo transfer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS

NCT02801565

Polycystic Ovary Syndrome

UNKNOWN NA

Low-dose GH Supplementation Increases Clinical Pregnancy Rate

NCT02359695

Infertility

COMPLETED PHASE1

Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET

NCT03071172

Ovarian Hyperstimulation Syndrome

UNKNOWN PHASE3

Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders

NCT03759301

Infertility, Female

COMPLETED PHASE4

To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference

NCT06091436

Infertility

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Poor Ovarian Response

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GH AQ

Conventional ovarian stimulation proctol without rhGH

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Conventional ovarian stimulation proctol without rhGH

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female, age 30-42 years old.
* Diagnosis of POR (2011 ESHRE Bologna Standard).
* At least two previous IVF failure history.
* Voluntarily to sign the "informed consent".

Exclusion Criteria

* Severe acute and chronic liver and kidney disease，Such as liver cirrhosis, acute and chronic renal failure, hepatitis B virus activity period, etc.；Liver and kidney dysfunction.
* Endocrine and metabolic diseases，eg, diabetes、Thyroid function hyperthyroidism, Thyroid dysfunction, cushing's syndrome, hyperprolactinemia，hyperandrogenism.
* Related diseases affecting outcome of IVF pregnancy，eg, hydrosalpinx, hysteromyoma≥4cm, adenomyosis, stage III and IV endometriosis, untreated endometrial lesions, uterine malformation, genital tuberculosis, malignant tumor of reproductive system （include endometrial carcinoma, cervical carcinoma, ovarian cancer, fallopian tube carcinoma）.
* Allergic to E. coli expression product and its excipients.
* Subjects who participated in the past three months or are participating in other drug clinical researchers.
* IVF failure history≥3.
* The researchers consider who is not suitable for enrolling the group.

Minimum Eligible Age

30 Years

Maximum Eligible Age

42 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No